. Cytokinetics, a biotechnology company, had hoped that by focusing on improving the function of muscle, not nerves, it could have an impact on lung function in patients with amyotrophic lateral sclerosis, popularly known as Lou Gehrig's disease, a nerve-destroying disorder. It didn't work.
from Forbes Real Time https://www.forbes.com/sites/matthewherper/2017/11/21/cytokinetics-als-drug-fails/
via IFTTT
No comments:
Post a Comment